Recent News

• 01.12.2026 - ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update
• 01.05.2026 - ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026
• 11.05.2025 - ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update
• 10.29.2025 - ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025
• 08.06.2025 - ADMA Biologics 2Q 2025 Earnings Call
• 08.06.2025 - ADMA Biologics 2Q 2025 Earnings Call
• 08.06.2025 - ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
• 08.06.2025 - ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update

Recent Filings

• 01.12.2026 - 8-K Current report
• 01.12.2026 - EX-99.1 EX-99.1
• 12.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.05.2025 - EX-99.1 EX-99.1
• 11.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.05.2025 - 8-K Current report
• 10.24.2025 - 144 Report of proposed sale of securities
• 10.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.16.2025 - 4 Statement of changes in beneficial ownership of securities